Table 1 Baseline characteristics of the human subjects

From: Autoantibody landscape and functional role of anti-C-C motif chemokine receptor 8 autoantibodies in systemic sclerosis: post-hoc analysis of a B-cell depletion trial

 

SSc on RTX

SSc on placebo

HC

(n = 24)

(n = 21)

(n = 45)

Basic features

 Sex

  Female

22 (91.7%)

19 (90.5%)

41 (91.1%)

  Male

2 (8.3%)

2 (9.5%)

4 (8.9%)

 Age, years

48.79 (15.50)

49.24 (9.66)

44.09 (14.05)

 Disease duration, months

96.75 (73.75)

77.29 (64.69)

NA

 mRSS

13.58 (3.26)

15.67 (5.43)

NA

 ILD presence

24 (100.0%)

19 (90.5%)

NA

 ILD severity

1.25 (0.44)

1.05 (0.50)

NA

Pulmonary function

 %FVC

87.42 (15.91)

90.19 (18.61)

NA

 %DLco

84.55 (19.63)

83.12 (14.56)

NA

Laboratory tests

 SP-A, ng/mL

40.81 (25.81)

43.45 (29.76)

NA

 SP-D, ng/mL

153.11 (80.93)

165.99 (133.82)

NA

 KL-6, U/mL

771.42 (759.63)

667.10 (720.64)

NA

 BNP, ng/mL

32.71 (58.86)

23.33 (13.92)

NA

 IgA, mg/mL

205.29 (65.69)

229.81 (85.52)

NA

 IgG, mg/mL

1349.12 (371.67)

1421.71 (548.83)

NA

 IgM, mg/mL

127.75 (44.68)

94.52 (39.89)

NA

Seum autoantibody levels

 ATA, U/mL

80.24 (65.11)

69.91 (67.25)

NA

 ACA, U/mL

22.75 (49.80)

19.08 (40.08)

NA

 ARA, U/mL

20 ± 37

17 ± 37

NA

 RNP, U/mL

20.26 (36.67)

16.63 (36.60)

NA

SF-36 score

 Bodily pain

62.67 (26.35)

58.48 (24.37)

NA

 General health

46.71 (14.01)

46.14 (14.87)

NA

 Mental health

70.00 (19.45)

70.24 (19.40)

NA

 Physical functioning

80.83 (15.99)

75.71 (15.83)

NA

 Role, emotional

80.90 (25.83)

79.76 (28.33)

NA

 Role, physical

69.79 (25.65)

71.43 (21.34)

NA

 Social functioning

79.17 (26.50)

81.55 (15.11)

NA

 Vaitality

48.44 (25.29)

51.49 (15.55)

NA

HAQ-DI score

 total

0.32 (0.48)

0.45 (0.41)

NA

 HAQ1 (dressing and grooming)

0.29 (0.62)

0.38 (0.50)

NA

 HAQ2 (arising)

0.04 (0.20)

0.19 (0.40)

NA

 HAQ3 (eating)

0.58 (0.93)

0.90 (0.89)

NA

 HAQ4 (walking)

0.04 (0.20)

0.24 (0.44)

NA

 HAQ5 (hygiene)

0.12 (0.34)

0.19 (0.40)

NA

 HAQ6 (reach)

0.38 (0.71)

0.43 (0.68)

NA

 HAQ7 (grip)

0.62 (0.82)

0.71 (0.64)

NA

 HAQ8 (common daily activities)

0.38 (0.82)

0.52 (0.81)

NA

  1. Data are n (%), mean (SD), or median (range). SSc systemic sclerosis, RTX rituximab, HC healthy control, mRSS modified Rodnan skin score,ILD interstitial lung disease, % FVC percent predicted forced vital capacity, %DLco percent predicted diffusing capacity for carbon monoxide, KL-6 sialylated carbohydrate antigen Krebs von den Lungen-6, SP-A surfactant protein-A,SP-D surfactant protein-D, BNP brain natriuretic peptide, ATA anti-topoisomerase antibody, ACA anti-centromere antibody,ARA anti-RNA polymerase III antibody, RNP anti-ribonucleoprotein antibody, SF-36 36-item short-form general health survey, HAQ-DI health assessment questionnaire disability index.